Enanta Pharmaceuticals
ENTA
#7360
Rank
โ‚น40.09 B
Marketcap
โ‚น1,389
Share price
5.92%
Change (1 day)
160.39%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Total assets

Total assets on the balance sheet as of September 2025 : โ‚น25.33 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's total assets are โ‚น25.33 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Enanta Pharmaceuticals - Total assets on balance sheet (from 2011 to 2025)

Total assets by year

Year Total assets Change
2024-09-30โ‚น31.57 B-17.89%
2023-09-30โ‚น38.45 B25.84%
2022-09-30โ‚น30.55 B-6.22%
2021-09-30โ‚น32.58 B-9.07%
2020-09-30โ‚น35.83 B3.14%
2019-09-30โ‚น34.73 B15.67%
2018-09-30โ‚น30.03 B40.79%
2017-09-30โ‚น21.33 B13.46%
2016-09-30โ‚น18.80 B16.63%
2015-09-30โ‚น16.12 B67.79%
2014-09-30โ‚น9.60 B31.25%
2013-09-30โ‚น7.32 B165.55%
2012-09-30โ‚น2.75 B115.19%
2011-09-30โ‚น1.28 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
AbbVie
ABBV
โ‚น12.085 T 47,596.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น17.402 T 68,583.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚น2.243 T 8,756.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น11.692 T 46,045.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น8.744 T 34,412.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น9.683 T 38,117.59%๐Ÿ‡จ๐Ÿ‡ญ Switzerland